Literature DB >> 18068102

Leuprolide--a GnRH agonist--prevents restraint stress-induced immunosuppression via sex steroid-independent peripheral mechanism in mice.

S N Umathe1, P V Dixit, M M Wanjari, M P Ullewar.   

Abstract

Gonadotropin-releasing hormone (GnRH) and sex steroids are known to modulate the immune system. To find out whether GnRH analogue can be useful to prevent the stress-induced immunosuppression, mice were treated with leuprolide (50 microg/mouse, s.c.) 30 min prior to restraint stress and immunological parameters were studied. Leuprolide prevented stress-induced decrease in relative weights of thymus, total leukocyte count and sheep red blood cells challenged humoral and cell-mediated immune reaction. Prior administration of GnRH antagonist (10 ng/mouse) through i.c.v. route did not alter the immunological effects of leuprolide. Further, the observed effect of leuprolide remained unaffected in castrated and ovariectomized mice. Thus, the investigations revealed that leuprolide prevented stress-induced immunosuppression through a peripheral mechanism, which is independent of systemic sex steroids.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18068102     DOI: 10.1016/j.intimp.2007.10.011

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  3 in total

Review 1.  Sex steroid ablation: an immunoregenerative strategy for immunocompromised patients.

Authors:  E Velardi; J A Dudakov; M R M van den Brink
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

2.  Luteinizing hormone receptor deficiency increases the susceptibility to alkylating agent-induced lymphomagenesis in mice.

Authors:  Yinghao Yu; Fangping Yuan; Xian Li; Dexin Lin; Zijian Lan; C V Rao; Zhenmin Lei
Journal:  Horm Cancer       Date:  2010-10       Impact factor: 3.869

3.  Hypothalamic neurohormones and immune responses.

Authors:  J Luis Quintanar; Irene Guzmán-Soto
Journal:  Front Integr Neurosci       Date:  2013-08-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.